[Federal Register: January 25, 1999 (Volume 64, Number 15)]
[Notices]               
[Page 3703]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25ja99-67]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
FDA In Vitro Diagnostic Products; Public Workshop

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA), Los Angeles District 
Office, in cooperation with the Orange County Regulatory Affairs 
Discussion Group (OCRA) is announcing the following public workshop: 
FDA In Vitro Diagnostic (IVD) Products. The workshop will address 
issues related to the manufacture of IVD products by Southern 
California and Arizona IVD manufacturers.
    Date and Time: The workshop will be held on Tuesday, February 2, 
1999, 8:15 a.m. to 5:30 p.m.
    Location: The workshop will be held at the Food and Drug 
Administration, Los Angeles District Office, 19900 MacArthur Blvd., 
suite 300, Irvine, CA 92612.
    Contact: Michael O. Stokke, Supervisory Consumer Safety Officer, 
Food and Drug Administration, 19900 MacArthur Blvd., suite 300, Irvine, 
CA 92612, 949-798-7790, FAX 949-798-7771, e-mail 
``mstokke@ora.fda.gov'', or Ken Michael, OCRA Programs Chair, 619-487-
5676, FAX 619-485-0829.
    Registration: Send registration information (including name, title, 
firm name, address, telephone, fax number, and fee) to OCRA, FDA IVD 
Products Workshop, 5405 Alton Pkwy., suite 5A-624, Irvine, CA 92604, by 
Monday, January 25, 1999. There is a $100 registration fee payable to 
OCRA (address above) for the workshop. The fee will cover actual 
expenses including refreshments, materials, and speaker expenses. The 
workshop will continue through lunch, which will be provided. Due to 
space limitations, attendance is limited to 200 persons, and only 1 
person per organization may attend. If space is still available, 
additional persons from the same organization may be admitted.
    If you need special accommodations due to a disability, please 
contact Michael O. Stokke at least 7 days in advance.

    Dated: January 15, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-1522 Filed 1-22-99; 8:45 am]
BILLING CODE 4160-01-F